AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | A206884 | MACLEODS PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.3161
per ea
Lowest NADAC/Unit
$0.2257
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342019307AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 | EA | Generic | — | 2026-08-19 |
| 33342019310AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 | EA | Generic | — | 2026-08-19 |
| 33342019107AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 | EA | Generic | — | 2026-08-19 |
| 33342019110AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 | EA | Generic | — | 2026-08-19 |
| 33342019207AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 | EA | Generic | — | 2026-08-19 |
| 33342019210AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 | EA | Generic | — | 2026-08-19 |
| 33342019007AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 | EA | Generic | — | 2026-08-19 |
| 33342019010AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.